The company said, “Outset reiterated 2025 revenue guidance of $115 million to $125 million, and non-GAAP gross margin guidance in the high-30% range. Additionally, the company continues to expect to use less than $50 million of cash in 2025 as compared to the $103 million used in 2024.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OM:
- Positive Outlook for Outset Medical: Buy Rating and $15 Price Target Amid Share Adjustments and Market Trends
- Outset Medical price target adjusted to $15 at Stifel after reverse stock split
- Outset Medical trading resumes
- Outset Medical trading halted, volatility trading pause
- Outset Medical trading halted, news pending